ISSN: "08044643" - OpacWWW

Skocz do pozycji: 1 1.

Tytuł :: Safety of GH after treatment for childhood cancer.
Autorzy :: van Santen HM; Pediatric Endocrinology, Princess Màxima Center for Pediatric Oncology and Wilhelmina Children's Hospital, Utrecht, the Netherlands.; Pokaż więcej
Źródło :: European journal of endocrinology [Eur J Endocrinol] 2020 Dec; Vol. 183 (6), pp. C15-C18.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Cancer Survivors*
Human Growth Hormone/*administration & dosage
Human Growth Hormone/*adverse effects
Neoplasm Recurrence, Local/*chemically induced
Neoplasms/*drug therapy
Child ; Humans ; Neoplasm Recurrence, Local/diagnosis ; Neoplasms/diagnosis
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 2 2.

Tytuł :: Rare CNVs provide novel insights into the molecular basis of GH and IGF-1 insensitivity.
Autorzy :: Cottrell E; Centre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine & Dentistry, Queen Mary University of London, London, UK.
Cabrera CP; Centre for Translational Bioinformatics, Queen Mary University of London, London, UK.; NIHR Barts Cardiovascular Biomedical Research Centre, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Ishida M; University College London, Great Ormond Street Institute of Child Health, London, UK.
Chatterjee S; Centre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine & Dentistry, Queen Mary University of London, London, UK.
Greening J; University Hospitals of Leicester NHS Trust, Leicester, UK.
Wright N; The University of Sheffield Faculty of Medicine, Dentistry and Health, Sheffield, UK.
Bossowski A; Department of Pediatrics, Endocrinology and Diabetes with a Cardiology Unit, Medical University of Bialystok, Bialystok, Poland.
Dunkel L; Centre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine & Dentistry, Queen Mary University of London, London, UK.
Deeb A; Paediatric Endocrinology Department, Mafraq Hospital, Abu Dhabi, United Arab Emirates.
Basiri IA; Mubarak Al-kabeer Hospital, Jabriya, Kuwait.
Rose SJ; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
Mason A; Royal Hospital for Children, Glasgow, UK.
Bint S; Viapath, Guy's Hospital, London, UK.
Ahn JW; Addenbrookes Hospital, Cambridge, UK.
Hwa V; Cincinnati Center for Growth Disorders, Division of Endocrinology, Cincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Metherell LA; Centre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine & Dentistry, Queen Mary University of London, London, UK.
Moore GE; University College London, Great Ormond Street Institute of Child Health, London, UK.
Storr HL; Centre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine & Dentistry, Queen Mary University of London, London, UK.; Pokaż więcej
Źródło :: European journal of endocrinology [Eur J Endocrinol] 2020 Dec; Vol. 183 (6), pp. 581-595.
Typ publikacji :: Journal Article
MeSH Terms :: DNA Copy Number Variations/*genetics
Genetic Testing/*methods
Human Growth Hormone/*genetics
Insulin-Like Growth Factor I/*genetics
Adolescent ; Child ; Child, Preschool ; Cohort Studies ; Female ; Human Growth Hormone/blood ; Humans ; Infant ; Insulin-Like Growth Factor I/metabolism ; Male
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 3 3.

Tytuł :: Pegvisomant and Pasireotide LAR as second line therapy in acromegaly: clinical effectiveness and predictors of response.
Autorzy :: Chiloiro S; Pituitary Unit, Department of Endocrinology and Diabetes, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.; Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy.
Giampietro A; Pituitary Unit, Department of Endocrinology and Diabetes, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.
Mirra F; Pituitary Unit, Department of Endocrinology and Diabetes, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.
Donfrancesco F; Pituitary Unit, Department of Endocrinology and Diabetes, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.
Tartaglione T; Department of Radiology, Istituto Dermatopatico dell'Immacolata, IRCCS, Rome, Italy.; Istituto di Radiologica, Università Cattolica del Sacro Cuore, Rome, Italy.
Mattogno PP; Department of Neurosurgery, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.
Angelini F; Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy.
Liverana L; Department of Neurosurgery, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.
Gessi M; Department di Pathology, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.
Carmelo A; Department of Neurosurgery, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.
Rindi G; Department di Pathology, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.; Istitute of Pathology, Università Cattolica del Sacro Cuore, Rome, Italy.
Giustina A; Endocrinology Vita-Salute San Raffaele University, IRCCS, San Raffaele Hospital, Milano, Italy.
Fleseriu M; Departments of Medicine (Endocrinology) and Neurological Surgery, and Pituitary Center, Oregon Health & Science University, Portland, Oregon, USA.
Pontecorvi A; Pituitary Unit, Department of Endocrinology and Diabetes, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.; Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy.
De Marinis L; Pituitary Unit, Department of Endocrinology and Diabetes, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.; Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy.
Bianchi A; Pituitary Unit, Department of Endocrinology and Diabetes, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.; Pokaż więcej
Źródło :: European journal of endocrinology [Eur J Endocrinol] 2021 Feb; Vol. 184 (2), pp. 217-229.
Typ publikacji :: Journal Article; Observational Study
MeSH Terms :: Acromegaly/*drug therapy
Human Growth Hormone/*analogs & derivatives
Somatostatin/*analogs & derivatives
Acromegaly/metabolism ; Acromegaly/pathology ; Adenoma/drug therapy ; Adenoma/metabolism ; Adenoma/pathology ; Adolescent ; Adult ; Aged ; Chemotherapy, Adjuvant ; Cross-Sectional Studies ; Delayed-Action Preparations ; Dose-Response Relationship, Drug ; Drug Therapy, Combination ; Female ; Growth Hormone-Secreting Pituitary Adenoma/drug therapy ; Growth Hormone-Secreting Pituitary Adenoma/metabolism ; Growth Hormone-Secreting Pituitary Adenoma/pathology ; Human Growth Hormone/administration & dosage ; Humans ; Insulin-Like Growth Factor I/analysis ; Insulin-Like Growth Factor I/metabolism ; Male ; Middle Aged ; Prognosis ; Retrospective Studies ; Somatostatin/administration & dosage ; Treatment Outcome ; Young Adult
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 4 4.

Tytuł :: Growth hormone therapy at the time of Covid-19 pandemic: adherence and drug supply issues.
Autorzy :: Giavoli C; Endocrinology Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.; Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
Profka E; Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
Giancola N; Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
Rodari G; Endocrinology Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.; Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
Giacchetti F; Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
Ferrante E; Endocrinology Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.
Arosio M; Endocrinology Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.; Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
Mantovani G; Endocrinology Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.; Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.; Pokaż więcej
Źródło :: European journal of endocrinology [Eur J Endocrinol] 2020 Oct; Vol. 183 (4), pp. L13-L15.
Typ publikacji :: Letter
MeSH Terms :: Hormone Replacement Therapy*
Growth Hormone/*deficiency
Human Growth Hormone/*therapeutic use
Hypopituitarism/*drug therapy
Medication Adherence/*statistics & numerical data
Adolescent ; Adult ; Aged ; Betacoronavirus ; COVID-19 ; Child ; Child, Preschool ; Coronavirus Infections/epidemiology ; Female ; Human Growth Hormone/supply & distribution ; Humans ; Infant ; Italy/epidemiology ; Male ; Middle Aged ; Pandemics ; Pneumonia, Viral/epidemiology ; SARS-CoV-2 ; Young Adult
: Opinia redakcyjna

Szczegóły

Skocz do pozycji: 5 5.

Tytuł :: Influence of growth hormone therapy on the occurrence of a second neoplasm in survivors of childhood cancer.
Autorzy :: Thomas-Teinturier C; Cancer and Radiation, CESP, Unit 1018 INSERM, Villejuif, France.; University Paris-Saclay, Villejuif, France.; Department of Pediatric Endocrinology, AP-HP, Université Paris Saclay, site Bicetre, Le Kremlin Bicêtre, France.
Oliver-Petit I; Department of Pediatric Endocrinology, Children Hospital, Toulouse, France.
Pacquement H; Department of Pediatrics Oncology, Institut Curie, Paris, France.
Fresneau B; Cancer and Radiation, CESP, Unit 1018 INSERM, Villejuif, France.; University Paris-Saclay, Villejuif, France.; Department of Pediatrics Oncology, Institut Gustave Roussy, Villejuif, France.
Allodji RS; Cancer and Radiation, CESP, Unit 1018 INSERM, Villejuif, France.; University Paris-Saclay, Villejuif, France.; Department of Research Gustave Roussy, Villejuif, France.
Veres C; Cancer and Radiation, CESP, Unit 1018 INSERM, Villejuif, France.; University Paris-Saclay, Villejuif, France.; Department of Research Gustave Roussy, Villejuif, France.
Bolle S; Department of Radiotherapy Oncology, Institut Gustave Roussy, Villejuif, France.
Berchery D; Centre Claudius Régaud, Toulouse, France.
Demoor-Goldschmidt C; Cancer and Radiation, CESP, Unit 1018 INSERM, Villejuif, France.; University Paris-Saclay, Villejuif, France.; Department of Pediatrics Oncology, CHU Angers, Angers, France.
Haddy N; Cancer and Radiation, CESP, Unit 1018 INSERM, Villejuif, France.; University Paris-Saclay, Villejuif, France.; Department of Research Gustave Roussy, Villejuif, France.
Diallo I; Cancer and Radiation, CESP, Unit 1018 INSERM, Villejuif, France.; University Paris-Saclay, Villejuif, France.; Department of Research Gustave Roussy, Villejuif, France.
de Vathaire F; Cancer and Radiation, CESP, Unit 1018 INSERM, Villejuif, France.; University Paris-Saclay, Villejuif, France.; Department of Research Gustave Roussy, Villejuif, France.; Pokaż więcej
Źródło :: European journal of endocrinology [Eur J Endocrinol] 2020 Oct; Vol. 183 (4), pp. 471-480.
Typ publikacji :: Journal Article
MeSH Terms :: Cancer Survivors/*statistics & numerical data
Human Growth Hormone/*therapeutic use
Neoplasms, Second Primary/*epidemiology
Adolescent ; Adult ; Aged ; Brain Neoplasms/chemically induced ; Brain Neoplasms/epidemiology ; Case-Control Studies ; Child ; Child, Preschool ; Cohort Studies ; Cranial Irradiation/adverse effects ; Female ; Follow-Up Studies ; France/epidemiology ; Hormone Replacement Therapy/adverse effects ; Hormone Replacement Therapy/statistics & numerical data ; Humans ; Infant ; Infant, Newborn ; Male ; Meningeal Neoplasms/chemically induced ; Meningeal Neoplasms/epidemiology ; Meningioma/chemically induced ; Meningioma/epidemiology ; Middle Aged ; Neoplasms, Second Primary/chemically induced ; Retrospective Studies ; Young Adult
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 6 6.

Tytuł :: Growth hormone retesting during puberty: a cohort study.
Autorzy :: Cavarzere P; Pediatric Division, Department of Pediatrics, University Hospital of Verona, Verona, Italy.
Gaudino R; Pediatric Division, Department of Pediatrics, University Hospital of Verona, Verona, Italy.; Pediatric Clinic, Department Surgical Sciences, Dentistry, Gynecology and Pediatrics, University of Verona, Verona, Italy.
Sandri M; Data Methods and Systems Statistical Laboratory, University of Brescia, Brescia, Italy.
Ramaroli DA; Pediatric Division, Department of Pediatrics, University Hospital of Verona, Verona, Italy.
Pietrobelli A; Pediatric Division, Department of Pediatrics, University Hospital of Verona, Verona, Italy.; Pediatric Clinic, Department Surgical Sciences, Dentistry, Gynecology and Pediatrics, University of Verona, Verona, Italy.
Zaffanello M; Pediatric Division, Department of Pediatrics, University Hospital of Verona, Verona, Italy.; Pediatric Clinic, Department Surgical Sciences, Dentistry, Gynecology and Pediatrics, University of Verona, Verona, Italy.
Guzzo A; Laboratory Unit, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.
Salvagno GL; Laboratory Unit, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.
Piacentini G; Pediatric Division, Department of Pediatrics, University Hospital of Verona, Verona, Italy.; Pediatric Clinic, Department Surgical Sciences, Dentistry, Gynecology and Pediatrics, University of Verona, Verona, Italy.
Antoniazzi F; Pediatric Division, Department of Pediatrics, University Hospital of Verona, Verona, Italy.; Pediatric Clinic, Department Surgical Sciences, Dentistry, Gynecology and Pediatrics, University of Verona, Verona, Italy.; Regional Center for the Diagnosis and Treatment of Children and Adolescents Rare Skeletal Disorders, Pediatric Clinic, Department of Surgical Sciences, Dentistry, Gynecology and Pediatrics, University of Verona, Verona, Italy.; Pokaż więcej
Źródło :: European journal of endocrinology [Eur J Endocrinol] 2020 Jun 01; Vol. 182 (6), pp. 559-567.
Typ publikacji :: Journal Article
MeSH Terms :: Human Growth Hormone/*deficiency
Puberty/*metabolism
Child ; Female ; Humans ; Insulin-Like Growth Factor I/analysis ; Male ; Retrospective Studies
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 7 7.

Tytuł :: Growth hormone treatments and cognitive functioning in children with Prader-Willi syndrome.
Autorzy :: Deal CL; Endocrine and Diabetes Service, CHU-Ste-Justine, Sainte-Justine Hospital, Montreal, Quebec, Canada.
Rogol AD; University of Virginia, Charlottesville, Virginia, USA.; Pokaż więcej
Źródło :: European journal of endocrinology [Eur J Endocrinol] 2020 Jun; Vol. 182 (6), pp. C21-C25.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Cognition/*drug effects
Human Growth Hormone/*therapeutic use
Prader-Willi Syndrome/*drug therapy
Prader-Willi Syndrome/*psychology
Child ; Child, Preschool ; Humans ; Recombinant Proteins/therapeutic use
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 8 8.

Tytuł :: Pegvisomant and not somatostatin receptor ligands (SRLs) is first-line medical therapy for acromegaly.
Autorzy :: van der Lely AJ; Division of Endocrinology and the Rotterdam Pituitary Centre, Department of Medicine, Erasmus University MC, Rotterdam, The Netherlands.
Kuhn E; Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires Paris-Saclay, Hôpital de Bicêtre, Service d'Endocrinologie et des Maladies de la Reproduction, Centre de Référence des Maladies Rares de l'Hypophyse, Le Kremlin Bicêtre, France.
Muhammad A; Division of Endocrinology and the Rotterdam Pituitary Centre, Department of Medicine, Erasmus University MC, Rotterdam, The Netherlands.
Coopmans EC; Division of Endocrinology and the Rotterdam Pituitary Centre, Department of Medicine, Erasmus University MC, Rotterdam, The Netherlands.
Neggers SJ; Division of Endocrinology and the Rotterdam Pituitary Centre, Department of Medicine, Erasmus University MC, Rotterdam, The Netherlands.
Chanson P; Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires Paris-Saclay, Hôpital de Bicêtre, Service d'Endocrinologie et des Maladies de la Reproduction, Centre de Référence des Maladies Rares de l'Hypophyse, Le Kremlin Bicêtre, France.; Université Paris-Saclay, Univ. Paris-Sud, Inserm, Signalisation Hormonale, Physiopathologie Endocrinienne et Métabolique, Le Kremlin-Bicêtre, France.; Pokaż więcej
Źródło :: European journal of endocrinology [Eur J Endocrinol] 2020 Jun; Vol. 182 (6), pp. D17-D29.
Typ publikacji :: Journal Article
MeSH Terms :: Acromegaly/*drug therapy
Human Growth Hormone/*analogs & derivatives
Receptors, Somatotropin/*therapeutic use
Human Growth Hormone/antagonists & inhibitors ; Human Growth Hormone/therapeutic use ; Humans ; Treatment Outcome
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 9 9.

Tytuł :: MANAGEMENT OF ENDOCRINE DISEASE: Does gender matter in the management of acromegaly?
Autorzy :: Lenders NF; Garvan Institute of Medical Research; Department of Endocrinology, St Vincent's Hospital; and St Vincent's Clinical School, Faculty of Medicine, the University of New South Wales, Sydney, Australia.
McCormack AI; Garvan Institute of Medical Research; Department of Endocrinology, St Vincent's Hospital; and St Vincent's Clinical School, Faculty of Medicine, the University of New South Wales, Sydney, Australia.
Ho KKY; Garvan Institute of Medical Research; Department of Endocrinology, St Vincent's Hospital; and St Vincent's Clinical School, Faculty of Medicine, the University of New South Wales, Sydney, Australia.; Pokaż więcej
Źródło :: European journal of endocrinology [Eur J Endocrinol] 2020 May; Vol. 182 (5), pp. R67-R82.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Acromegaly/*drug therapy
Human Growth Hormone/*analogs & derivatives
Age Factors ; Disease Management ; Dose-Response Relationship, Drug ; Female ; Human Growth Hormone/administration & dosage ; Human Growth Hormone/therapeutic use ; Humans ; Male ; Quality of Life ; Sex Factors ; Treatment Outcome
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 10 10.

Tytuł :: Cognitive functioning in children with Prader-Willi syndrome during 8 years of growth hormone treatment.
Autorzy :: Donze SH; Dutch Growth Research Foundation, Rotterdam, The Netherlands.; Erasmus University Medical Centre/Sophia Children's Hospital, Department of Paediatrics, Subdivision of Endocrinology, Rotterdam, The Netherlands.
Damen L; Dutch Growth Research Foundation, Rotterdam, The Netherlands.; Erasmus University Medical Centre/Sophia Children's Hospital, Department of Paediatrics, Subdivision of Endocrinology, Rotterdam, The Netherlands.
Mahabier EF; Dutch Growth Research Foundation, Rotterdam, The Netherlands.
Hokken-Koelega ACS; Dutch Growth Research Foundation, Rotterdam, The Netherlands.; Erasmus University Medical Centre/Sophia Children's Hospital, Department of Paediatrics, Subdivision of Endocrinology, Rotterdam, The Netherlands.; Pokaż więcej
Źródło :: European journal of endocrinology [Eur J Endocrinol] 2020 Apr; Vol. 182 (4), pp. 405-411.
Typ publikacji :: Journal Article
MeSH Terms :: Cognitive Dysfunction/*drug therapy
Human Growth Hormone/*therapeutic use
Prader-Willi Syndrome/*drug therapy
Prader-Willi Syndrome/*psychology
Adolescent ; Age Factors ; Child ; Child, Preschool ; Cognition/drug effects ; Cohort Studies ; Female ; Genotype ; Human Growth Hormone/administration & dosage ; Humans ; Infant ; Longitudinal Studies ; Male ; Netherlands ; Prader-Willi Syndrome/genetics ; Prospective Studies ; Treatment Outcome ; Wechsler Scales
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 11 11.

Tytuł :: All-cause mortality in patients with acromegaly treated with pegvisomant: an ACROSTUDY analysis.
Autorzy :: Tritos NA; Neuroendocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Mattsson AF; Pfizer Endocrine Care, Pfizer Health AB, Sollentuna, Sweden.
Vila G; Division of Endocrinology and Metabolism, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
Biller BMK; Neuroendocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Klibanski A; Neuroendocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Valluri S; Global Biometrics and Data Management, Pfizer Inc, New York, New York, USA.
Hey-Hadavi J; Pfizer Endocrine Care, Inc, New York, New York, USA.
Kelepouris N; Pfizer Endocrine Care, Inc, New York, New York, USA.
Jimenez C; Department of Endocrine Neoplasia and Hormonal Disorders, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Pokaż więcej
Źródło :: European journal of endocrinology [Eur J Endocrinol] 2020 Mar; Vol. 182 (3), pp. 285-292.
Typ publikacji :: Journal Article
MeSH Terms :: Mortality*
Acromegaly/*drug therapy
Human Growth Hormone/*analogs & derivatives
Receptors, Somatotropin/*antagonists & inhibitors
Acromegaly/metabolism ; Adult ; Age Factors ; Aged ; Cause of Death ; Cohort Studies ; Female ; Human Growth Hormone/therapeutic use ; Humans ; Insulin-Like Growth Factor I/metabolism ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Proportional Hazards Models ; Retrospective Studies ; Risk Factors ; Time Factors ; Time-to-Treatment
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 12 12.

Tytuł :: Mortality in acromegaly decreased in the last decade: a systematic review and meta-analysis.
Autorzy :: Bolfi F; Department of Internal Medicine, São Paulo State University/UNESP, Medical School, Sao Paulo, Brazil.
Neves AF; Department of Internal Medicine, São Paulo State University/UNESP, Medical School, Sao Paulo, Brazil.
Boguszewski CL; Endocrine Division (SEMPR), Department of Internal Medicine, Federal University of Parana, Curitiba, Brazil.
Nunes-Nogueira VS; Department of Internal Medicine, São Paulo State University/UNESP, Medical School, Sao Paulo, Brazil.; Pokaż więcej
Źródło :: European journal of endocrinology [Eur J Endocrinol] 2019 Nov; Vol. 181 (5), pp. L5-L6.
Typ publikacji :: Letter; Meta-Analysis; Systematic Review
MeSH Terms :: Acromegaly/*blood
Acromegaly/*mortality
Human Growth Hormone/*blood
Humans ; Mortality/trends
: Raport

Szczegóły

Skocz do pozycji: 13 13.

Tytuł :: Determinants of the growth hormone nadir during oral glucose tolerance test in adults.
Autorzy :: Monaghan PJ; Department of Clinical Biochemistry, The Christie Pathology Partnership, The Christie NHS Foundation Trust; University of Manchester, Faculty of Medical and Human Sciences, Institute of Inflammation and Repair, Manchester, UK.
Trainer PJ; Department of Endocrinology, The Christie NHS Foundation Trust; University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.; Pokaż więcej
Źródło :: European journal of endocrinology [Eur J Endocrinol] 2019 Nov; Vol. 181 (5), pp. C17-C20.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Acromegaly/*blood
Acromegaly/*diagnosis
Glucose Tolerance Test/*methods
Human Growth Hormone/*blood
Adult ; Glucose Tolerance Test/standards ; Humans
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 14 14.

Tytuł :: Growth hormone secretion, fatigue and quality of life after childhood traumatic brain injury.
Autorzy :: Daskas N; Department of Paediatric Endocrinology, University Hospitals Bristol, Bristol, UK.
Sharples P; Department of Paediatric Neurology, University Hospitals Bristol, Bristol, UK.
Likeman M; School of Clinical Sciences, University of Bristol, Bristol, UK.
Lightman S; Department of Radiology, University Hospitals Bristol, Bristol, UK.
Crowne EC; Department of Paediatric Endocrinology, University Hospitals Bristol, Bristol, UK.; Pokaż więcej
Źródło :: European journal of endocrinology [Eur J Endocrinol] 2019 Sep; Vol. 181 (3), pp. 331-338.
Typ publikacji :: Journal Article
MeSH Terms :: Brain Injuries, Traumatic/*blood
Brain Injuries, Traumatic/*psychology
Fatigue/*blood
Fatigue/*psychology
Human Growth Hormone/*blood
Quality of Life/*psychology
Adolescent ; Adult ; Brain Injuries, Traumatic/epidemiology ; Child ; Depression/blood ; Depression/epidemiology ; Depression/psychology ; Fatigue/epidemiology ; Female ; Humans ; Male ; Young Adult
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 15 15.

Tytuł :: MANAGEMENT OF ENDOCRINE DISEASE: Individualised management of acromegaly.
Autorzy :: Bollerslev J; Section of Specialized Endocrinology, Department of Endocrinology, Medical Clinic, Oslo University Hospital.; Faculty of Medicine, University of Oslo, Oslo, Norway.
Heck A; Section of Specialized Endocrinology, Department of Endocrinology, Medical Clinic, Oslo University Hospital.; Faculty of Medicine, University of Oslo, Oslo, Norway.
Olarescu NC; Section of Specialized Endocrinology, Department of Endocrinology, Medical Clinic, Oslo University Hospital.; Pokaż więcej
Źródło :: European journal of endocrinology [Eur J Endocrinol] 2019 Aug; Vol. 181 (2), pp. R57-R71.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Disease Management*
Acromegaly/*blood
Acromegaly/*therapy
Human Growth Hormone/*blood
Precision Medicine/*methods
Acromegaly/diagnosis ; Combined Modality Therapy/methods ; Combined Modality Therapy/trends ; Humans ; Precision Medicine/trends
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 16 16.

Tytuł :: MANAGEMENT OF ENDOCRINE DISEASE: Bone disorders associated with acromegaly: mechanisms and treatment.
Autorzy :: Mazziotti G; Department of Biomedical Sciences, Humanitas University.; Endocrine, Diabetes and Andrology Unit, Humanitas Clinical and Research Center, IRCCS, Rozzano, Milan, Italy.
Lania AGA; Department of Biomedical Sciences, Humanitas University.; Endocrine, Diabetes and Andrology Unit, Humanitas Clinical and Research Center, IRCCS, Rozzano, Milan, Italy.
Canalis E; Departments of Orthopaedic Surgery and Medicine, The UConn Musculoskeletal Institute, UConn Health, Farmington, Connecticut, USA.; Pokaż więcej
Źródło :: European journal of endocrinology [Eur J Endocrinol] 2019 Aug; Vol. 181 (2), pp. R45-R56.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Disease Management*
Acromegaly/*blood
Acromegaly/*therapy
Human Growth Hormone/*blood
Acromegaly/diagnostic imaging ; Bone Density/physiology ; Bone Diseases/blood ; Bone Diseases/diagnostic imaging ; Bone Diseases/therapy ; Bone Remodeling/physiology ; Fractures, Bone/blood ; Fractures, Bone/diagnostic imaging ; Fractures, Bone/prevention & control ; Humans ; Treatment Outcome
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 17 17.

Tytuł :: Determinants of the growth hormone nadir during oral glucose tolerance test in adults.
Autorzy :: Schilbach K; Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany.
Gar C; Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany.
Lechner A; Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany.
Nicolay SS; Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany.
Schwerdt L; Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany.
Haenelt M; Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany.
Dal J; Department of Endocrinology, Aalborg University Hospital, Aalborg, Denmark.; Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark.
Jørgensen JL; Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark.
Störmann S; Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany.
Schopohl J; Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany.
Bidlingmaier M; Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany.; Pokaż więcej
Źródło :: European journal of endocrinology [Eur J Endocrinol] 2019 Jul; Vol. 181 (1), pp. 55-67.
Typ publikacji :: Evaluation Study; Journal Article; Multicenter Study
MeSH Terms :: Glucose Tolerance Test*
Acromegaly/*diagnosis
Human Growth Hormone/*analysis
Immunoassay/*methods
Adult ; Aged ; Female ; Humans ; Male ; Menstrual Cycle/blood ; Middle Aged ; Prospective Studies ; Reference Values ; Retrospective Studies ; Sensitivity and Specificity ; Young Adult
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 18 18.

Tytuł :: Long-term growth hormone (GH) replacement of adult GH deficiency (GHD) benefits the heart.
Autorzy :: Ziagaki A; Interdisciplinary Centre of Metabolism, Endocrinology, Diabetes and Metabolism.
Blaschke D; Clinic of Cardiology, Charité - University Medicine Berlin, Campus Virchow Klinikum, Berlin, Germany.
Haverkamp W; Clinic of Cardiology, Charité - University Medicine Berlin, Campus Virchow Klinikum, Berlin, Germany.
Plöckinger U; Interdisciplinary Centre of Metabolism, Endocrinology, Diabetes and Metabolism.; Pokaż więcej
Źródło :: European journal of endocrinology [Eur J Endocrinol] 2019 Jul; Vol. 181 (1), pp. 79-91.
Typ publikacji :: Journal Article
MeSH Terms :: Time Factors*
Growth Hormone/*administration & dosage
Heart Failure/*etiology
Hormone Replacement Therapy/*methods
Human Growth Hormone/*deficiency
Adult ; Drug Administration Schedule ; Echocardiography ; Female ; Follow-Up Studies ; Heart/drug effects ; Humans ; Insulin-Like Growth Factor I/drug effects ; Male ; Middle Aged ; Natriuretic Peptide, Brain/blood ; Peptide Fragments/blood ; Treatment Outcome
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 19 19.

Tytuł :: Long-term treatment with pegvisomant: observations from 2090 acromegaly patients in ACROSTUDY.
Autorzy :: Buchfelder M; Department of Neurosurgery, University of Erlangen-Nürnberg, Erlangen, Germany.
van der Lely AJ; Department of Medicine, Erasmus University MC, Rotterdam, the Netherlands.
Biller BMK; Neuroendocrine Unit, Massachusetts General Hospital, Boston, Massachusetts, USA.
Webb SM; Endocrinologia (Malalties de la Hipòfisi), Hospital Sant Pau, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
Brue T; Department of Endocrinology, Centre de Référence des Maladies Rares d'Origine Hypophysaire, Hôpital de la Conception, Marseille, France.
Strasburger CJ; Department of Medicine for Endocrinology, Diabetes and Nutritional Medicine, Charité Universitätsmedizin, Campus Mitte, Berlin, Germany.
Ghigo E; University Hospital Città Salute e Scienza, Turin, Italy.
Camacho-Hubner C; Endocrine Care Global Medical Affairs, Pfizer Inc., New York City, New York, USA.
Pan K; Endocrine Care Global Clinical Affairs, Pfizer Inc., Collegeville, Pennsylvania, USA.
Lavenberg J; Endocrine Care Global Clinical Affairs, Pfizer Inc., Collegeville, Pennsylvania, USA.
Jönsson P; Endocrine Care, Pfizer Health AB, Sollentuna, Sweden.
Hey-Hadavi JH; Endocrine Care Global Medical Affairs, Pfizer Inc., New York City, New York, USA.; Pokaż więcej
Źródło :: European journal of endocrinology [Eur J Endocrinol] 2018 Dec 01; Vol. 179 (6), pp. 419-427.
Typ publikacji :: Journal Article; Pragmatic Clinical Trial
MeSH Terms :: Internationality*
Acromegaly/*diagnosis
Acromegaly/*drug therapy
Human Growth Hormone/*analogs & derivatives
Human Growth Hormone/*metabolism
Acromegaly/epidemiology ; Adolescent ; Adult ; Aged ; Aged, 80 and over ; Child ; Child, Preschool ; Drug Administration Schedule ; Female ; Follow-Up Studies ; Human Growth Hormone/administration & dosage ; Humans ; Infant ; Male ; Middle Aged ; Treatment Outcome ; Young Adult
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 20 20.

Tytuł :: Efficacy and Safety of switching to Pasireotide in Acromegaly Patients controlled with Pegvisomant and Somatostatin Analogues: PAPE extension study.
Autorzy :: Muhammad A; Endocrinology Section, Department of Medicine.
Coopmans EC; Endocrinology Section, Department of Medicine.
Delhanty PJD; Endocrinology Section, Department of Medicine.
Dallenga AHG; Department of Neurosurgery, Pituitary Center Rotterdam, Erasmus University Medical Center, Rotterdam, the Netherlands.
Haitsma IK; Department of Neurosurgery, Pituitary Center Rotterdam, Erasmus University Medical Center, Rotterdam, the Netherlands.
Janssen JAMJL; Endocrinology Section, Department of Medicine.
van der Lely AJ; Endocrinology Section, Department of Medicine.
Neggers SJCMM; Endocrinology Section, Department of Medicine.; Pokaż więcej
Źródło :: European journal of endocrinology [Eur J Endocrinol] 2018 Oct 12; Vol. 179 (5), pp. 269-277. Date of Electronic Publication: 2018 Oct 12.
Typ publikacji :: Journal Article
MeSH Terms :: Acromegaly/*drug therapy
Human Growth Hormone/*analogs & derivatives
Insulin-Like Growth Factor I/*metabolism
Somatostatin/*analogs & derivatives
Acromegaly/blood ; Drug Substitution ; Follow-Up Studies ; Glucose Tolerance Test ; Hormone Antagonists/therapeutic use ; Human Growth Hormone/therapeutic use ; Humans ; Insulin/blood ; Octreotide/therapeutic use ; Prospective Studies ; Somatostatin/adverse effects ; Somatostatin/therapeutic use ; Treatment Outcome
: Czasopismo naukowe

Szczegóły

Informacja

Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""08044643"" wg kryterium: ISSN

Aktywne filtry:

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Język